rs3743798

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020686.6(ABAT):​c.*512G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 284,430 control chromosomes in the GnomAD database, including 26,244 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 12520 hom., cov: 31)
Exomes 𝑓: 0.46 ( 13724 hom. )

Consequence

ABAT
NM_020686.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.307

Publications

9 publications found
Variant links:
Genes affected
ABAT (HGNC:23): (4-aminobutyrate aminotransferase) 4-aminobutyrate aminotransferase (ABAT) is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde. The active enzyme is a homodimer of 50-kD subunits complexed to pyridoxal-5-phosphate. The protein sequence is over 95% similar to the pig protein. GABA is estimated to be present in nearly one-third of human synapses. ABAT in liver and brain is controlled by 2 codominant alleles with a frequency in a Caucasian population of 0.56 and 0.44. The ABAT deficiency phenotype includes psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. [provided by RefSeq, Jul 2008]
TMEM186 (HGNC:24530): (transmembrane protein 186) This gene encodes a potential transmembrane protein. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 16-8781942-G-A is Benign according to our data. Variant chr16-8781942-G-A is described in ClinVar as Benign. ClinVar VariationId is 321104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.46 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABATNM_020686.6 linkc.*512G>A 3_prime_UTR_variant Exon 16 of 16 ENST00000268251.13 NP_065737.2 P80404X5D8S1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABATENST00000268251.13 linkc.*512G>A 3_prime_UTR_variant Exon 16 of 16 1 NM_020686.6 ENSP00000268251.8 P80404
ABATENST00000396600.6 linkc.*512G>A 3_prime_UTR_variant Exon 16 of 16 5 ENSP00000379845.2 P80404
TMEM186ENST00000564869.1 linkn.32-498C>T intron_variant Intron 1 of 2 4

Frequencies

GnomAD3 genomes
AF:
0.400
AC:
60748
AN:
151852
Hom.:
12517
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.286
Gnomad AMI
AF:
0.290
Gnomad AMR
AF:
0.351
Gnomad ASJ
AF:
0.542
Gnomad EAS
AF:
0.421
Gnomad SAS
AF:
0.400
Gnomad FIN
AF:
0.451
Gnomad MID
AF:
0.453
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.396
GnomAD4 exome
AF:
0.460
AC:
60881
AN:
132460
Hom.:
13724
Cov.:
0
AF XY:
0.454
AC XY:
32050
AN XY:
70548
show subpopulations
African (AFR)
AF:
0.289
AC:
1251
AN:
4334
American (AMR)
AF:
0.387
AC:
2384
AN:
6160
Ashkenazi Jewish (ASJ)
AF:
0.552
AC:
1805
AN:
3268
East Asian (EAS)
AF:
0.450
AC:
2929
AN:
6506
South Asian (SAS)
AF:
0.417
AC:
8792
AN:
21062
European-Finnish (FIN)
AF:
0.496
AC:
2791
AN:
5622
Middle Eastern (MID)
AF:
0.478
AC:
241
AN:
504
European-Non Finnish (NFE)
AF:
0.479
AC:
37500
AN:
78252
Other (OTH)
AF:
0.472
AC:
3188
AN:
6752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1541
3081
4622
6162
7703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.400
AC:
60771
AN:
151970
Hom.:
12520
Cov.:
31
AF XY:
0.395
AC XY:
29323
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.286
AC:
11852
AN:
41436
American (AMR)
AF:
0.352
AC:
5373
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.542
AC:
1880
AN:
3468
East Asian (EAS)
AF:
0.421
AC:
2168
AN:
5146
South Asian (SAS)
AF:
0.400
AC:
1931
AN:
4822
European-Finnish (FIN)
AF:
0.451
AC:
4776
AN:
10580
Middle Eastern (MID)
AF:
0.459
AC:
135
AN:
294
European-Non Finnish (NFE)
AF:
0.465
AC:
31557
AN:
67934
Other (OTH)
AF:
0.395
AC:
835
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1840
3680
5519
7359
9199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.425
Hom.:
5634
Bravo
AF:
0.389
Asia WGS
AF:
0.404
AC:
1404
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Gamma-aminobutyric acid transaminase deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
3.1
DANN
Benign
0.47
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3743798; hg19: chr16-8875799; API